Rifampicin (RIF) is a Solana-based cryptocurrency launched on Pump.science, a groundbreaking platform that funds and gamifies longevity experiments. The RIF token represents fractional ownership of experiments testing Rifampicin, a compound with potential lifespan-extending properties.
RIF tokens finance experiments that evaluate Rifampicin's effects on longevity in model organisms like worms (C. elegans) and flies. Token holders gain access to live data streams from experiments, showcasing survival rates, activity metrics, and lifespan extension percentages (PLE).
As RIF’s market cap reaches specific thresholds, new rounds of experiments are automatically funded, moving research from simpler organisms to more complex ones. If experiments prove successful, RIF holders can benefit from licensing agreements or commercialization of Rifampicin as a supplement or research chemical.
RIF crypto bridges the gap between decentralized finance and innovative health research, offering both speculative opportunities and contributions to advancements in human healthspan.
